H. Razzaghi, K. Wieand, A. Pinkney, C. Bailey
Research replication in real-world data is essential to build trust in evidence from clinical studies. However, methods for conducting and reporting these efforts are lacking, particularly related to data fitness and limitations. We demonstrate the importance of incorporating systematic fitness testing by replicating a single-center observational study of hydroxyurea for children with severe sickle cell disease (SS/S{beta}0) in a multi-institutional learning network using EHR data (PEDSnet). An AS-IS arm applied the original studys criteria with no major data quality adjustments, while a Data Fitness Enhanced (DFE) arm used systematic data fitness assessment to inform adjustments to cohort eligibility criteria and variable definitions; both arms then replicated the original studys primary analyses. Data quality checks in the DFE arm refined cohort accuracy and improved hydroxyurea capture, drug era computation, and hematology specialist mapping. The DFE cohort produced average treatment effects with higher face validity and greater concordance with the original study (e.g., change in ED visits: -0.44 (CI -0.60, -0.26) versus -0.36 (CI -0.57, -0.16) in the original study) than the AS-IS cohort (-0.08 (CI -0.26, 0.09)), which yielded several implausible results. These findings show that superficially plausible cohort characteristics do not guarantee valid results without transparent, systematic data fitness assessment.